ID
15747
Description
Efficacy of Repaglinide in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01698931
Link
https://clinicaltrials.gov/show/NCT01698931
Keywords
Versions (1)
- 6/10/16 6/10/16 -
Uploaded on
June 10, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes NCT01698931
Eligibility Diabetes NCT01698931
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
systemic treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C1515119
Description
drug or alcohol dependence
Data type
boolean
Alias
- UMLS CUI [1]
- C0038586
Description
significant concomitant disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
hepatic disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0023895
Description
cardiac problems
Data type
boolean
Alias
- UMLS CUI [1]
- C0262402
Description
proliferative retinopathy
Data type
boolean
Alias
- UMLS CUI [1]
- C0339467
Description
allergy to trial product
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C3854006
Description
women pregnancy
Data type
boolean
Alias
- UMLS CUI [1]
- C3831118
Description
BMI
Data type
boolean
Alias
- UMLS CUI [1]
- C1305855
Similar models
Eligibility Diabetes NCT01698931
- StudyEvent: Eligibility
C0359086 (UMLS CUI [2])
C3854006 (UMLS CUI [1,2])